These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24386659)

  • 1. Litgation over for AstraZeneca’s Crestor® drug.
    Sklan A
    Pharm Pat Anal; 2013 May; 2(3):301. PubMed ID: 24386659
    [No Abstract]   [Full Text] [Related]  

  • 2. Teva v. AstraZeneca and secret prior art under 102(g)(2).
    Lee S; Knierim M
    Nat Biotechnol; 2012 Sep; 30(9):831-3. PubMed ID: 22965051
    [No Abstract]   [Full Text] [Related]  

  • 3. Statin utilisation--recognising the role of the invisible hand.
    Minhas R
    Int J Clin Pract; 2007 Jan; 61(1):3-6. PubMed ID: 17229171
    [No Abstract]   [Full Text] [Related]  

  • 4. Engineered in India--patent law 2.0.
    Kapczynski A
    N Engl J Med; 2013 Aug; 369(6):497-9. PubMed ID: 23862973
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosuvastatin (Crestor) and rhabdomyolysis.
    Wooltorton E
    CMAJ; 2004 Jul; 171(2):129. PubMed ID: 15262879
    [No Abstract]   [Full Text] [Related]  

  • 6. India's rejection of Novartis's patent is but a small step in the right direction.
    Bhaumik S
    BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223
    [No Abstract]   [Full Text] [Related]  

  • 7. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 8. Using Crestor--and all statins--safely. Some simple steps can help minimize or avoid muscle problems from these cholesterol-lowering drugs.
    Harv Heart Lett; 2005 Sep; 16(1):3. PubMed ID: 16211723
    [No Abstract]   [Full Text] [Related]  

  • 9. Patent. Battle lines are drawn over generic AIDS drug.
    AIDS Policy Law; 2005 Aug; 20(16):6. PubMed ID: 16161208
    [No Abstract]   [Full Text] [Related]  

  • 10. [By JUPITER! Disease mongering!].
    Welin L; Peterson M
    Lakartidningen; 2008 Dec; 105(51-52):3756; discussion 3756-7. PubMed ID: 19278103
    [No Abstract]   [Full Text] [Related]  

  • 11. The statin wars: why AstraZeneca must retreat.
    Lancet; 2003 Oct; 362(9393):1341. PubMed ID: 14585629
    [No Abstract]   [Full Text] [Related]  

  • 12. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 13. Complications and side effects. Crestor tested in PHAs.
    TreatmentUpdate; 2005; 17(4):6-7. PubMed ID: 17230630
    [No Abstract]   [Full Text] [Related]  

  • 14. Generics battle brand names over mortality of drug patents.
    Betz R
    J Healthc Resour Manag; 1995 Jul; 13(7):35-7. PubMed ID: 10144008
    [No Abstract]   [Full Text] [Related]  

  • 15. European Commission targets drug firms over illegal patent protection.
    Watson R
    BMJ; 2010 Jan; 340():c268. PubMed ID: 20080819
    [No Abstract]   [Full Text] [Related]  

  • 16. A generic problem.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):649. PubMed ID: 17130869
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary injunctions in generic and branded patent litigation.
    Cohen S; England P
    Expert Opin Ther Pat; 2013 Sep; 23(9):1083-6. PubMed ID: 23855903
    [No Abstract]   [Full Text] [Related]  

  • 18. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of commercial opportunity.
    Wyllie MG
    BJU Int; 2012 Feb; 109(3):E8-9. PubMed ID: 22243668
    [No Abstract]   [Full Text] [Related]  

  • 20. Legal challenge to India's patent laws threatens access to generic drugs, says charity.
    Moszynski P
    BMJ; 2011 Sep; 343():d5753. PubMed ID: 21908529
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.